Skip to content

A triumph for injectable PrEP, but a sobering result for oral PrEP

Professor Sinead Delany-Moretlwe presenting HPTN 084's study design

Women with HIV have sixfold increase in risk of cervical cancer

Image: National HPV vaccination launch programme, Addis Ababa. UNICEF Ethiopia. Creative Commons licence.

HIV is an independent risk factor for smoking-related cancers, especially in women

fotografierende/Pexels

Study of injectable PrEP reports the best efficacy seen yet for any form of PrEP in women

Image: GCIS/Government ZA. Creative Commons licence. Image is for illustrative purposes only.

Who benefits when men attend antenatal care with their partners?

'Improving Timely Linkage to Lifesaving Treatment'. Baylor College of Medicine Children's Foundation–Malawi / Robbie Flick / USAID. Creative Commons licence.

Similar benefits and barriers to injectables for HIV prevention and treatment reported by US women

CDC/Unsplash

Biological, clinical and ethical imperatives for involving diverse women in HIV clinical trials

Dr Catherine Orrell presenting to HIV Glasgow 2020.

Why do people in southern Africa stop taking PrEP?

Dominic Chavez / Global Financing Facility. Creative Commons licence. Image is for illustrative purposes only.

“Telling lies every day”: secrecy as a means of resisting stigma and asserting identity

Image: Lusaka, Zambia. Constance Mackworth-Young.